{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective from the specified list.", "method": "llm_batch", "batch_id": "batch_1_16748", "batch_size": 200, "batch_pos": 170, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "No high-potency verb, potent metaphor, superlative + harm noun, intensifier + harm noun, or critical alert phrase found.", "method": "llm_batch", "batch_id": "batch_2_18128", "batch_size": 200, "batch_pos": 131, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment describes a future possibility ('will be able to manufacture'), not realised impact.", "method": "llm_batch", "batch_id": "batch_3_14304", "batch_size": 200, "batch_pos": 64, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "Segment contains no question.", "method": "llm_batch", "batch_id": "batch_4_13908", "batch_size": 200, "batch_pos": 58, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment states it's too early to tell numbers but contains no explicit calming cues.", "method": "llm_batch", "batch_id": "batch_5_14052", "batch_size": 200, "batch_pos": 52, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_15924", "batch_size": 200, "batch_pos": 2, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_20824", "batch_size": 200, "batch_pos": 196, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "no", "rationale": "Describes past/ongoing events and scale, not capability/preparedness.", "method": "llm_batch", "batch_id": "batch_8_9072", "batch_size": 200, "batch_pos": 7, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "Reports uncertainty about a future quantity, not reporting current metrics.", "method": "llm_batch", "batch_id": "batch_9_15256", "batch_size": 200, "batch_pos": 175, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment states a current limitation regarding future capability, not speculation about relief.", "method": "llm_batch", "batch_id": "batch_10_4068", "batch_size": 200, "batch_pos": 124, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Quote from named/institutional speaker is a factual statement about manufacturing, not framing the threat/risk/safety.", "method": "llm_batch", "batch_id": "batch_11_19928", "batch_size": 200, "batch_pos": 119, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 12, "answer": "yes", "rationale": "No explicit framing cues remain; statement about manufacturing uncertainty is neutral.", "method": "llm_batch", "batch_id": "batch_12_19296", "batch_size": 200, "batch_pos": 119, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
